Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 4Anovulation 2Infertility 1Hyperandrogenism 1

Interventions

Clomiphene 12Metformin 6Letrozole 6Menotropins 5cetrorelix 4Triptorelin Pamoate 4Chorionic Gonadotropin 4follitropin alfa 3Inositol 3follitropin beta 2Surveys and Questionnaires 2Goserelin 2Gonadotropins 2Folic Acid 2Flutamide 2Cyclophosphamide 2testosterone undecanoate 1methyl N-acetylsibirosaminide 1drospirenone and ethinyl estradiol combination 1drospirenone 1Uterine Myomectomy 1Urofollitropin 1Thyrotropin 1Therapeutics 1Testosterone 1Sugars 1Solutions 1Sildenafil Citrate 1Psychiatric Rehabilitation 1Prostatectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Infertility × Glycoprotein Hormones, alpha Subunit × Clear all
NCT01081626 2014-02-13

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

Merck KGaA, Darmstadt, Germany

Phase 4 Completed
310 enrolled 18 charts

Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡